Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 07.11.2024
CytomX Therapeutics Мультипликаторы 2011-2024 | CTMX
Мультипликаторы по годам CytomX Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-325.6 | -1.2 | -8.1 | -12.7 | -2.8 | -8.2 | -23.6 | -7.0 | -3.8 | - | - | - | - |
P/S |
1.8 | 2.2 | 7.6 | 4.5 | 14.0 | 11.7 | 14.2 | 27.3 | 17.5 | - | - | - | - |
EPS |
-0.0 | -1.5 | -0.5 | -0.5 | -2.9 | - | -1.2 | -1.6 | -4.9 | -35.2 | -24.5 | - | - |
EV (Enterprise Value) |
417 млн | 272 млн | 417 млн | 480 млн | 478 млн | 776 млн | 1.17 млрд | 427 млн | 146 млн | 87.2 млн | 49.8 млн | - | - |
EBITDA per Share |
-0.06 | -1.51 | -0.49 | -0.47 | -3.07 | -1.82 | -1.2 | -1.6 | -3.72 | - | - | - | - |
EV/EBITDA |
-3.7 | -2.8 | -1.4 | -5.9 | -18.9 | -5.3 | -2.4 | - | - | - | - | ||
PEG |
-16.28 | -0.02 | -0.57 | -0.14 | 0.3 | 0.11 | -0.82 | -0.1 | 0.01 | - | - | - | - |
P/B |
-3.9 | -1.4 | -616.0 | -39.3 | 7.4 | 5.3 | 14.6 | 5.2 | 1.1 | - | - | - | - |
P/CF |
-3.3 | -1.1 | -2.4 | 58.0 | -2.7 | -8.8 | 6.0 | -97.6 | -4.7 | - | - | - | - |
ROE % |
1.20 | 115.82 | 7586.71 | 308.67 | -521.48 | -64.64 | -61.66 | -75.05 | -28.06 | - | - | - | - |
ROA % |
-0.28 | -38.07 | -10.26 | -6.69 | -38.92 | -18.51 | -10.84 | -29.58 | -17.94 | - | - | - | - |
ROCE % |
13.67 | 118.17 | 7604.14 | 309.67 | -555.46 | -21.68 | -13.75 | -36.48 | -18.30 | - | - | - | - |
Current Ratio |
0.8 | 0.8 | 1.0 | 1.0 | 1.2 | 4.5 | 6.4 | 5.3 | 12.1 | - | - | - | - |
DSO |
71.1 | 126.2 | 7.8 | 2.2 | 0.7 | 0.6 | 51.7 | 56.1 | 35.2 | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
71.1 | 126.2 | 7.8 | 2.2 | 0.8 | - | - | - | - | - | - | - | - |
Финансовый цикл |
71.1 | 126.2 | 7.8 | 2.2 | 0.8 | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально CytomX Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.07 | -0.08 | 0.17 | 0.04 | -0.02 | -0.05 | - | -0.44 | -0.45 | -0.49 | - | -0.35 | - | -0.26 | - | - | - | 0.27 | - | - | - | -0.31 | - | - | - | - | - | - | -0.69 | -0.23 | - | -0.4 | -0.39 | -0.44 | - | -14.26 | -7.56 | -7.56 | - | -4.86 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | 0.14 | - | - | -0.08 | - | -0.45 | -0.46 | -0.49 | - | -0.35 | -0.3 | -0.26 | - | -0.32 | -0.35 | -0.06 | - | -0.56 | -0.69 | -0.35 | -0.57 | -0.53 | -0.32 | -0.39 | - | -0.26 | -0.68 | -0.22 | - | -0.4 | -0.38 | -0.44 | - | -10.5 | -5.23 | -4.62 | - | -2.96 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-52.91 | -27.17 | -44.27 | 35.35 | 77.27 | 130.08 | 197.71 | 177.48 | 121.17 | 52.39 | -45.57 | -75.11 | -84.42 | -101.21 | -36.51 | -105.88 | -122.71 | -147.88 | -200.02 | -155.28 | -126.82 | -80.44 | -64.64 | -39.13 | -35.88 | -61.69 | -61.66 | -80.43 | -84.45 | -66.44 | -75.05 | -66.28 | -57.02 | -43.56 | -28.06 | -12.85 | 1.13 | 5.74 | 10.66 | 4.57 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
8.84 | 4.20 | 6.89 | -13.41 | -27.60 | -37.85 | -34.38 | -40.46 | -22.94 | -27.72 | -14.45 | -18.55 | -16.57 | -16.16 | -5.07 | -15.46 | -18.30 | -22.42 | -29.96 | -26.62 | -24.80 | -19.26 | -18.51 | -11.30 | -8.75 | -12.15 | -10.84 | -18.04 | -22.83 | -23.61 | -29.58 | -28.36 | -27.01 | -22.84 | -17.94 | -18.66 | -17.56 | -14.61 | -11.46 | -4.91 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-33.35 | -11.89 | -32.43 | 41.26 | 84.24 | 135.41 | 199.80 | 179.53 | 122.37 | 52.59 | -45.64 | -75.55 | -85.18 | -102.92 | -67.92 | -118.24 | -138.64 | -167.35 | -143.83 | -163.55 | -130.94 | -79.97 | -59.50 | -55.55 | -53.62 | -79.79 | -64.40 | -83.40 | -86.64 | -68.50 | -57.79 | -66.73 | -56.67 | -42.89 | -17.20 | -12.79 | 0.56 | 4.96 | 4.41 | 4.41 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.9 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 0.8 | 1.1 | - | 1.3 | 1.4 | 1.4 | 1.5 | 1.5 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.4 | 1.4 | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.2 | 1.6 | 1.6 | 1.6 | 1.6 | 2.8 | 2.8 | 2.8 | 2.8 | 1.0 | 1.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
8.4 | 29.0 | 17.2 | 7.5 | 5.5 | 72.0 | - | 7.0 | 3.6 | 9.1 | - | 4.7 | 4.7 | 4.4 | - | 4.1 | 4.4 | 0.8 | 0.1 | 0.1 | 0.1 | 0.2 | 0.8 | 0.7 | 0.4 | 32.9 | 34.2 | 38.3 | 105.7 | 48.1 | 31.4 | 57.0 | 63.7 | 52.0 | 17.1 | 17.5 | 16.6 | 58.9 | 91.9 | 44.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
8.4 | 29.0 | 17.2 | 7.5 | 5.5 | 72.0 | - | 7.0 | 3.6 | 9.1 | - | 4.7 | 4.7 | 4.4 | - | 4.1 | 4.4 | 0.8 | 0.1 | 0.1 | 0.1 | 0.2 | 0.8 | 0.7 | 0.4 | 32.9 | 34.2 | 38.3 | 105.7 | 48.1 | 31.4 | 57.0 | 63.7 | 52.0 | 17.1 | 17.5 | 16.6 | 58.9 | 91.9 | 44.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
8.4 | 29.0 | 17.2 | 7.5 | 5.5 | 72.0 | - | 7.0 | 3.6 | 9.1 | - | 4.7 | 4.7 | 4.4 | - | 4.1 | 4.4 | 0.8 | 0.1 | 0.1 | 0.1 | 0.2 | 0.8 | 0.7 | 0.4 | 32.9 | 34.2 | 38.3 | 105.7 | 48.1 | 31.4 | 57.0 | 63.7 | 52.0 | 17.1 | 17.5 | 16.6 | 58.9 | 91.9 | 44.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD